|
1
|
MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy.
|
J Transl Med
|
2012
|
0.97
|
|
2
|
New gene therapy strategies for cancer treatment: a review of recent patents.
|
Recent Pat Anticancer Drug Discov
|
2012
|
0.87
|
|
3
|
5-Fluorouracil derivatives: a patent review.
|
Expert Opin Ther Pat
|
2012
|
0.87
|
|
4
|
Cancer stem cells and their implication in breast cancer.
|
Eur J Clin Invest
|
2014
|
0.86
|
|
5
|
Human cardiac tissue induces transdifferentiation of adult stem cells towards cardiomyocytes.
|
Cytotherapy
|
2010
|
0.86
|
|
6
|
Nanomedicine: application areas and development prospects.
|
Int J Mol Sci
|
2011
|
0.84
|
|
7
|
5-fluorouracil derivatives induce differentiation mediated by tubulin and HLA class I modulation.
|
Med Chem
|
2007
|
0.83
|
|
8
|
New (RS)-benzoxazepin-purines with antitumour activity: The chiral switch from (RS)-2,6-dichloro-9-[1-(p-nitrobenzenesulfonyl)-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]-9H-purine.
|
Eur J Med Chem
|
2010
|
0.81
|
|
9
|
Antitumor properties of natural compounds and related molecules.
|
Recent Pat Anticancer Drug Discov
|
2013
|
0.80
|
|
10
|
A synthetic uracil derivative with antitumor activity through decreasing cyclin D1 and Cdk1, and increasing p21 and p27 in MCF-7 cells.
|
Breast Cancer Res Treat
|
2006
|
0.80
|
|
11
|
Anticancer activity of (1,2,3,5-tetrahydro-4,1-benzoxazepine-3-yl)-pyrimidines and -purines against the MCF-7 cell line: Preliminary cDNA microarray studies.
|
Bioorg Med Chem Lett
|
2008
|
0.79
|
|
12
|
Modulation of multidrug resistance gene expression in peripheral blood mononuclear cells of lung cancer patients and evaluation of their clinical significance.
|
Cancer Chemother Pharmacol
|
2012
|
0.79
|
|
13
|
Ultrastructural and molecular analyzes of insulin-producing cells induced from human hepatoma cells.
|
Cytotherapy
|
2010
|
0.79
|
|
14
|
E phage gene transfection enhances sensitivity of lung and colon cancer cells to chemotherapeutic agents.
|
Int J Oncol
|
2010
|
0.78
|
|
15
|
The cytotoxic activity of the phage E protein suppress the growth of murine B16 melanomas in vitro and in vivo.
|
J Mol Med (Berl)
|
2009
|
0.78
|
|
16
|
Transdifferentiation: why and how?
|
Cell Biol Int
|
2011
|
0.78
|
|
17
|
The selective cytotoxic activity in breast cancer cells by an anthranilic alcohol-derived acyclic 5-fluorouracil O,N-acetal is mediated by endoplasmic reticulum stress-induced apoptosis.
|
Eur J Med Chem
|
2012
|
0.77
|
|
18
|
Antiproliferative activity, cell-cycle dysregulation, and cellular differentiation: salicyl- and catechol-derived acyclic 5-fluorouracil O,N-acetals against breast cancer cells.
|
ChemMedChem
|
2007
|
0.77
|
|
19
|
Prognostic value of RT-PCR tyrosinase detection in peripheral blood of melanoma patients.
|
Dis Markers
|
2006
|
0.77
|
|
20
|
Synthesis and anticancer activity of (R,S)-9-(2,3-dihydro-1,4-benzoxathiin-3-ylmethyl)-9H-purines.
|
ChemMedChem
|
2008
|
0.76
|
|
21
|
Cumulative live birth rate after two single frozen embryo transfers (eSFET) versus a double frozen embryo transfer (DFET) with cleavage stage embryos: a retrospective cohort study.
|
J Assist Reprod Genet
|
2014
|
0.75
|
|
22
|
Anticancer activity and cDNA microarray studies of a (RS)-1,2,3,5-tetrahydro-4,1-benzoxazepine-3-yl]-6-chloro-9H-purine, and an acyclic (RS)-O,N-acetalic 6-chloro-7H-purine.
|
Eur J Med Chem
|
2011
|
0.75
|
|
23
|
Cell surface immobilization of GABAA Rs in cerebellar granule cells depends on the M3/M4 cytoplasmatic loop of the alpha 1 subunit.
|
Cells Tissues Organs
|
2008
|
0.75
|
|
24
|
Exosomes Derived from Breast Cancer Cells, Small Trojan Horses?
|
J Mammary Gland Biol Neoplasia
|
2015
|
0.75
|
|
25
|
Regiospecific microwave-assisted synthesis and cytotoxic activity against human breast cancer cells of (RS)-6-substituted-7- or 9-(2,3-dihydro-5H-1,4-benzodioxepin-3-yl)-7H- or -9H-purines.
|
Eur J Med Chem
|
2007
|
0.75
|
|
26
|
Differentiation: an encouraging approach to anticancer therapy.
|
Ital J Anat Embryol
|
2006
|
0.75
|
|
27
|
Gef gene therapy enhances the therapeutic efficacy of cytotoxics in colon cancer cells.
|
Biomed Pharmacother
|
2012
|
0.75
|